{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:17:15Z","timestamp":1783477035200,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["766214"],"award-info":[{"award-number":["766214"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016882","name":"European Resuscitation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017636","name":"Cancer Centre Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["91715337"],"award-info":[{"award-number":["91715337"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["2018-LYCo-008"],"award-info":[{"award-number":["2018-LYCo-008"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["864815"],"award-info":[{"award-number":["864815"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016058","name":"Stichting Lymph&Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.isci.2024.109640","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T11:54:30Z","timestamp":1711626870000},"page":"109640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies"],"prefix":"10.1016","volume":"27","author":[{"given":"Chiara","family":"Montironi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.M.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspard","family":"Cretenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esm\u00e9e A.","family":"Krap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Eldering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2431-6133","authenticated-orcid":false,"given":"Helga","family":"Simon-Molas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109640_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: The cell's response to p53","volume":"2","author":"Vousden","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"p53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109640_bib3","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial","volume":"123","author":"Stilgenbauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109640_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.beha.2016.08.002","article-title":"TP53 dysfunction in CLL: Implications for prognosis and treatment","volume":"29","author":"Te Raa","year":"2016","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.isci.2024.109640_bib6","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/annonc\/mdf185","article-title":"p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas","volume":"13","author":"Leroy","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2024.109640_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrc2715","article-title":"P53 and metabolism","volume":"9","author":"Vousden","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2006.05.036","article-title":"TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis","volume":"126","author":"Bensaad","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109640_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cmet.2013.06.019","article-title":"Metabolic regulation by p53 family members","volume":"18","author":"Berkers","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109640_bib12","doi-asserted-by":"crossref","first-page":"23780","DOI":"10.18632\/oncotarget.25267","article-title":"p53 and metabolism: From mechanism to therapeutics","volume":"9","author":"Simabuco","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.109640_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbcan.2018.06.001","article-title":"Control of metabolism by p53\u00a0\u2013 Cancer and beyond","volume":"1870","author":"Labuschagne","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2024.109640_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2024.109640_bib16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","article-title":"A Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3","volume":"28","author":"Tajan","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.isci.2024.109640_bib17","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.celrep.2019.02.037","article-title":"p53 Promotes Cancer Cell Adaptation to Glutamine Deprivation by Upregulating Slc7a3 to Increase Arginine Uptake","volume":"26","author":"Lowman","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.109640_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.2021013990","article-title":"Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment","volume":"140","author":"Chen","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: From mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109640_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098064","article-title":"The Prohibitin-Binding Compound Fluorizoline Activates the Integrated Stress Response through the eIF2alpha Kinase HRI","volume":"24","author":"S\u00e1nchez-Vera","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.109640_bib21","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood-2019-124826","article-title":"TP53 deficient\/mutant AMLs are resistant to individual BH3 mimetics: high efficacy of combined inhibition of Bcl-2 and Mcl-1","volume":"134","author":"Carter","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib22","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood.2020010167","article-title":"Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias","volume":"137","author":"Thijssen","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib23","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109640_bib24","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1093\/nar\/gng153","article-title":"Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways","volume":"31","author":"Eldering","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109640_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2403623","article-title":"Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation","volume":"19","author":"Mackus","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2024.109640_bib26","first-page":"e302","article-title":"Resistance to ABT-199 induced by microenvironmental signals in chronic lymphocytic leukemia can be counteracted by CD20 antibodies or kinase inhibitors","volume":"100","author":"Thijssen","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.isci.2024.109640_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ncb2172","article-title":"P53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase","volume":"13","author":"Jiang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2024.109640_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41586-019-1577-5","article-title":"alpha-Ketoglutarate links p53 to cell fate during tumour suppression","volume":"573","author":"Morris","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109640_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molcel.2013.02.008","article-title":"The B55alpha subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation","volume":"50","author":"Reid","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2024.109640_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neo.2021.01.004","article-title":"P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1\/2 and CDK9","volume":"23","author":"Tian","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.isci.2024.109640_bib31","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1200\/jco.2014.32.15_suppl.7015","article-title":"ABT-199 (GDC-0199) in relapsed\/refractory (R\/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): High complete- response rate and durable disease control","volume":"32","author":"Seymour","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109640_bib32","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.20.00948","article-title":"Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study","volume":"38","author":"Kater","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109640_bib33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib34","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1182\/blood-2016-01-688796","article-title":"The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism","volume":"127","author":"Anderson","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib35","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41418-020-00692-w","article-title":"Regulation of Bcl-XL by non-canonical NF-kappaB in the context of CD40-induced drug resistance in CLL","volume":"28","author":"Haselager","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2024.109640_bib36","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/onc.2015.464","article-title":"Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax","volume":"35","author":"Bajpai","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2024.109640_bib37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cbf.3121","article-title":"Inhibition of MCL-1 by obatoclax sensitizes Sp2\/0-Ag14 hybridoma cells to glutamine deprivation-induced apoptosis","volume":"33","author":"Harnett","year":"2015","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.isci.2024.109640_bib38","article-title":"A p53 score derived from TP53 CRISPR\/Cas9 HMCLs predicts survival and reveals major role of BAX in BH3 mimetics response","volume":"143","author":"Durand","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109640_bib40","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ncb801","article-title":"p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products","volume":"4","author":"Yin","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2024.109640_bib41","doi-asserted-by":"crossref","first-page":"D640","DOI":"10.1093\/nar\/gkad1045","article-title":"MetaboLights: open data repository for metabolomics","volume":"52","author":"Yurekten","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.109640_bib42","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1182\/blood-2008-03-146704","article-title":"c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches","volume":"112","author":"Hallaert","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib43","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance","volume":"114","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.isci.2024.109640_bib44","article-title":"CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells","volume":"8","author":"Martens","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/gcc.22350","article-title":"Guidelines for genomic array analysis in acquired haematological neoplastic disorders","volume":"55","author":"Schoumans","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.isci.2024.109640_bib46","unstructured":"ISCN 2020: An International System for Human Cytogenomic Nomenclature (2020) (Cytogenetic and Genome Research). (2020). (S. Karger)."},{"key":"10.1016\/j.isci.2024.109640_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.isci.2024.109640_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36293-4","article-title":"Correcting for natural isotope abundance and tracer impurity in MS-MS\/MS- and high-resolution-multiple-tracer-data from stable isotope labeling experiments with IsoCorrectoR","volume":"8","author":"Heinrich","year":"2018","journal-title":"Sci. Rep."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224008629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224008629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:38:04Z","timestamp":1783474684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224008629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2589004224008629"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109640","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109640"}}